傲農生物(603363.SH)擬聘容誠會計師事務所為2019年度審計機構
格隆匯11月19日丨傲農生物(603363.SH)公佈,公司於2019年11月19日召開的第二屆董事會第十七次會議審議通過了《關於公司聘任2019年度審計機構的議案》,擬聘任容誠會計師事務所(特殊普通合夥)為公司2019年度審計機構,同時改聘容誠會計師事務所(特殊普通合夥)為公司非公開發行股票的審計機構。
因公司原審計團隊離開致同會計師事務所(特殊普通合夥)並加入容誠會計師事務所(特殊普通合夥),為保持審計工作的連續性,公司擬聘任容誠會計師事務所(特殊普通合夥)為公司2019年度審計機構,為公司提供財務報告審計、內部控制審計及相關審核鑑證等服務,同時改聘容誠會計師事務所(特殊普通合夥)為公司非公開發行股票的審計機構,並提請股東大會授權公司經營管理層與其協商確定審計報酬。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.